SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043419
Filing Date
2021-08-11
Accepted
2021-08-11 16:02:16
Documents
76
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcvx-10q_20210630.htm   iXBRL 10-Q 3516505
2 EX-31.1 pcvx-ex311_9.htm EX-31.1 18265
3 EX-31.2 pcvx-ex312_7.htm EX-31.2 17872
4 EX-32.1 pcvx-ex321_8.htm EX-32.1 9399
5 EX-32.2 pcvx-ex322_6.htm EX-32.2 9411
  Complete submission text file 0001564590-21-043419.txt   10088109

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20210630.xsd EX-101.SCH 67685
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pcvx-20210630_cal.xml EX-101.CAL 56928
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pcvx-20210630_def.xml EX-101.DEF 231840
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20210630_lab.xml EX-101.LAB 504953
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20210630_pre.xml EX-101.PRE 396443
11 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-10q_20210630_htm.xml XML 1575291
Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39323 | Film No.: 211163327
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences